Sclerosis
|
phenotype |
Pathological Conditions, Signs and Symptoms
|
Pathologic Function
|
24
|
|
0.010 |
None |
1.000 |
1 |
|
2003 |
2003 |
Depressed bipolar I disorder
|
disease |
Mental Disorders
|
Mental or Behavioral Dysfunction
|
37
|
59
|
0.100 |
None |
1.000 |
1 |
2
|
2019 |
2019 |
Viral Load result
|
phenotype |
|
Finding
|
65
|
91
|
0.100 |
None |
1.000 |
1 |
1
|
2019 |
2019 |
Manic Disorder
|
disease |
Mental Disorders
|
Mental or Behavioral Dysfunction
|
76
|
|
0.300 |
None |
1.000 |
1 |
|
2019 |
2019 |
Depression, Bipolar
|
disease |
Mental Disorders
|
Mental or Behavioral Dysfunction
|
116
|
2
|
0.300 |
None |
1.000 |
1 |
|
2019 |
2019 |
HIV-1, RESISTANCE TO
|
phenotype |
|
Finding
|
147
|
526
|
0.100 |
None |
1.000 |
1 |
1
|
2019 |
2019 |
ACQUIRED IMMUNODEFICIENCY SYNDROME, PROGRESSION TO
|
phenotype |
|
Finding
|
147
|
526
|
0.100 |
None |
1.000 |
1 |
1
|
2019 |
2019 |
AIDS, PROGRESSION TO
|
phenotype |
|
Finding
|
147
|
526
|
0.100 |
None |
1.000 |
1 |
1
|
2019 |
2019 |
Dryness of eye
|
phenotype |
Eye Diseases
|
Sign or Symptom
|
149
|
1
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
HUMAN IMMUNODEFICIENCY VIRUS TYPE 1, SUSCEPTIBILITY TO
|
disease |
|
Finding
|
149
|
527
|
0.100 |
None |
1.000 |
1 |
1
|
2019 |
2019 |
Dry Eye Syndromes
|
disease |
Eye Diseases
|
Disease or Syndrome
|
156
|
1
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Primary central nervous system lymphoma
|
disease |
Neoplasms; Immune System Diseases; Nervous System Diseases; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
156
|
4
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
CUI: |
C0338831 |
Disease: |
Manic
|
Manic
|
disease |
Mental Disorders
|
Mental or Behavioral Dysfunction
|
166
|
8
|
0.300 |
None |
1.000 |
1 |
|
2019 |
2019 |
Oligospermia
|
disease |
Male Urogenital Diseases
|
Disease or Syndrome
|
217
|
72
|
0.010 |
None |
1.000 |
1 |
|
2016 |
2016 |
Dental caries
|
disease |
Stomatognathic Diseases
|
Disease or Syndrome
|
330
|
126
|
0.100 |
None |
1.000 |
1 |
1
|
2012 |
2012 |
Rectal Carcinoma
|
disease |
Digestive System Diseases; Neoplasms
|
Neoplastic Process
|
472
|
112
|
0.010 |
None |
1.000 |
1 |
|
2011 |
2011 |
Metastatic melanoma
|
disease |
Neoplasms
|
Neoplastic Process
|
504
|
42
|
0.300 |
None |
|
0 |
1
|
|
|
Adult Rhabdomyosarcoma
|
disease |
Neoplasms
|
Neoplastic Process
|
509
|
12
|
0.010 |
None |
1.000 |
1 |
|
2004 |
2004 |
Childhood Rhabdomyosarcoma
|
disease |
Neoplasms
|
Neoplastic Process
|
517
|
12
|
0.010 |
None |
1.000 |
1 |
|
2004 |
2004 |
Adenocarcinoma of large intestine
|
disease |
Digestive System Diseases; Neoplasms
|
Neoplastic Process
|
543
|
432
|
0.300 |
None |
|
0 |
1
|
|
|
Rhabdomyosarcoma
|
disease |
Neoplasms
|
Neoplastic Process
|
565
|
20
|
0.010 |
None |
1.000 |
1 |
|
2004 |
2004 |
Hormone refractory prostate cancer
|
disease |
Neoplasms; Male Urogenital Diseases
|
Neoplastic Process
|
683
|
29
|
0.010 |
None |
1.000 |
1 |
|
2016 |
2016 |
Systolic Pressure
|
phenotype |
|
Clinical Attribute
|
843
|
1931
|
0.100 |
None |
1.000 |
1 |
1
|
2015 |
2015 |
Diffuse Large B-Cell Lymphoma
|
disease |
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
1043
|
127
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Bipolar Disorder
|
disease |
Mental Disorders
|
Mental or Behavioral Dysfunction
|
1183
|
839
|
0.400 |
None |
1.000 |
1 |
1
|
2019 |
2019 |